CURATIS N AG (CURN) - Total Assets

Latest as of June 2025: CHF54.52 Million CHF ≈ $68.93 Million USD

Based on the latest financial reports, CURATIS N AG (CURN) holds total assets worth CHF54.52 Million CHF (≈ $68.93 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check total reinvestment intensity of CURATIS N AG to assess the company's total reinvestment commitment from operating cash flow.

CURATIS N AG - Total Assets Trend (2002–2024)

This chart illustrates how CURATIS N AG's total assets have evolved over time, based on quarterly financial data. Check CURN operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

CURATIS N AG - Asset Composition Analysis

Current Asset Composition (December 2024)

CURATIS N AG's total assets of CHF54.52 Million consist of 10.6% current assets and 89.4% non-current assets.

Asset Category	Amount (CHF)	% of Total Assets
Cash & Equivalents	CHF3.01 Million	5.4%
Accounts Receivable	CHF1.56 Million	2.8%
Inventory	CHF1.32 Million	2.4%
Property, Plant & Equipment	CHF0.00	0.0%
Intangible Assets	CHF49.38 Million	88.9%
Goodwill	CHF0.00	0.0%

Asset Composition Trend (2002–2024)

This chart illustrates how CURATIS N AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see CURATIS N AG market capitalisation.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: CURATIS N AG's current assets represent 10.6% of total assets in 2024, a decrease from 36.2% in 2002.
Cash Position: Cash and equivalents constituted 5.4% of total assets in 2024, down from 6.5% in 2002.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 88.0% of total assets, an increase from 3.0% in 2002.
Asset Diversification: The largest asset category is intangible assets at 88.9% of total assets.

CURATIS N AG Competitors by Total Assets

Key competitors of CURATIS N AG based on total assets are shown below.

Company	Country	Total Assets
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Sweden	Skr81.26 Billion
Aurobindo Pharma Limited NSE:AUROPHARMA	India	Rs585.02 Billion
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	China	CN¥14.18 Billion
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	China	CN¥19.57 Billion
Tianjin Chase Sun Pharmaceutical Co Ltd SHE:300026	China	CN¥10.37 Billion
Zhejiang Hisoar Pharmaceutical Co Ltd SHE:002099	China	CN¥7.28 Billion
Xeris Pharmaceuticals Inc NASDAQ:XERS	USA	$392.01 Million
Procter & Gamble Health Limited NSE:PGHL	India	Rs8.94 Billion

CURATIS N AG - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.50	0.92	1.09
Quick Ratio	1.07	0.72	1.09
Cash Ratio	0.62	0.51	0.00
Working Capital	CHF1.65 Million	CHF-555.00K	CHF17.00K

CURATIS N AG - Advanced Valuation Insights

This section examines the relationship between CURATIS N AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.06
Latest Market Cap to Assets Ratio	1.61
Asset Growth Rate (YoY)	46180.0%
Total Assets	CHF55.54 Million
Market Capitalization	$89.64 Million USD

Valuation Analysis

Above Book Valuation: The market values CURATIS N AG's assets above their book value (1.61x), reflecting positive investor sentiment about the company's future prospects.

Rapid Asset Growth: CURATIS N AG's assets grew by 46180.0% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for CURATIS N AG (2002–2024)

The table below shows the annual total assets of CURATIS N AG from 2002 to 2024.

Year	Total Assets	Change
2024-12-31	CHF55.54 Million ≈ $70.21 Million	+46180.00%
2023-12-31	CHF120.00K ≈ $151.71K	-99.15%
2022-12-31	CHF14.05 Million ≈ $17.76 Million	+10227.94%
2021-12-31	CHF136.00K ≈ $171.94K	+7.09%
2020-12-31	CHF127.00K ≈ $160.56K	-94.16%
2019-12-31	CHF2.17 Million ≈ $2.75 Million	-0.73%
2018-12-31	CHF2.19 Million ≈ $2.77 Million	-67.24%
2017-12-31	CHF6.68 Million ≈ $8.45 Million	-5.70%
2016-12-31	CHF7.09 Million ≈ $8.96 Million	-11.01%
2015-12-31	CHF7.97 Million ≈ $10.07 Million	-19.95%
2014-12-31	CHF9.95 Million ≈ $12.58 Million	-14.75%
2013-12-31	CHF11.67 Million ≈ $14.76 Million	-39.27%
2012-12-31	CHF19.22 Million ≈ $24.30 Million	+56.62%
2011-12-31	CHF12.27 Million ≈ $15.52 Million	-8.15%
2010-12-31	CHF13.36 Million ≈ $16.89 Million	+61.52%
2009-12-31	CHF8.27 Million ≈ $10.46 Million	+62.45%
2008-12-31	CHF5.09 Million ≈ $6.44 Million	-45.61%
2007-12-31	CHF9.36 Million ≈ $11.84 Million	-32.69%
2006-12-31	CHF13.91 Million ≈ $17.58 Million	-59.87%
2005-12-31	CHF34.66 Million ≈ $43.82 Million	-41.97%
2004-12-31	CHF59.73 Million ≈ $75.51 Million	-16.27%
2003-12-31	CHF71.33 Million ≈ $90.18 Million	+3.32%
2002-12-31	CHF69.04 Million ≈ $87.29 Million	--

About CURATIS N AG

SW:CURN Switzerland Drug Manufacturers - Specialty & Generic

Market Cap

$153.06 Million

CHF121.06 Million CHF

Market Cap Rank

#19709 Global

#190 in Switzerland

Share Price

CHF23.50

Change (1 day)

-3.29%

52-Week Range

CHF10.45 - CHF26.00

All Time High

CHF891.52